ED Coding & Reimbursement Alert - 2005 Issue 33
Medication Billing: Ditch 90782, Reach For G0355 For Injections
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare-oriented billing guidance for in-office Avonex administration for multiple sclerosis patients. It is aimed at practices, neurologists, and billing staff who handle drug administration claims and related supply reporting. The discussion covers payer policy context, a Medicare transmittal, a local coverage decision, and the service and drug codes referenced in that setting.
Why This Topic Matters
Understanding how payer policy affects billing for in-office medication administration helps practices submit claims more accurately and avoid denials or miscoding. The article is especially relevant when a practice supplies the drug, when carrier policy differs, or when supervision requirements affect claim handling.
What You Will Learn
- How Medicare policy affects billing for in-office Avonex injections
- Which general claim components are discussed for administration and drug supply reporting
- How payer coverage and supervision context can affect billing workflows
- What documentation and policy checks may be relevant before submitting claims
Who Should Read This
- Medical billing staff
- Neurology practices
- Physicians
- Coding professionals
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com